92Indexed trials
Market Rank #24 · Evidence Tier A
Portugal
Neuroscience Intelligence
Portugal neuroscience intelligence: 92 indexed trials, 73 institutions, research score 36.46.
32Recruiting
73Research institutions
36.5Research score
Evidence profile
56Sponsors
21Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 36.5 · Data confidence 100.00 · Evidence 36.5
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
alzheimers18trials
parkinsons18trials
epilepsy12trials
multiple_sclerosis9trials
stroke5trials
pain_neuropathy4trials
schizophrenia3trials
autism3trials
other_psychiatry3trials
migraine_headache3trials
Leading indexed sponsors
Hoffmann-La Roche10trials
Bial - Portela C S.A.10trials
Merck Sharp & Dohme LLC5trials
University of Coimbra4trials
Boehringer Ingelheim4trials
Novo Nordisk A/S2trials
Aveiro University2trials
Genzyme, a Sanofi Company2trials
Celgene2trials
GlaxoSmithKline2trials